Compounds > efavirenz

efavirenz and Opportunistic Infections

efavirenz has been researched along with Opportunistic Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abidin, ZZ; Chidambaram, SK; Fahrni, ML; Lazzarino, AI; Misran, NFL1
Goliath, R; Meintjes, G; Seldon, R; Wilkinson, KA; Wilkinson, RJ1

Other Studies

2 other study(ies) available for efavirenz and Opportunistic Infections

ArticleYear
Clinical predictors of efavirenz-based regimen treatment durability: A two-year case-control study of antiretroviral-naïve patients.
    Journal of infection and public health, 2023, Volume: 16, Issue:1

    Topics: Anti-HIV Agents; Anti-Retroviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Opportunistic Infections; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome; Viral Load

2023
Immunological characterisation of an unmasking TB-IRIS case.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2012, Mar-02, Volume: 102, Issue:6

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Cytokines; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Male; Opportunistic Infections; Stavudine; Thymic Factor, Circulating; Tuberculosis, Pulmonary

2012